Trial Profile
A trial to assess first-line therapy with trastuzumab in patients with HER2 positive, metastatic breast cancer who were pre-exposed to trastuzumab for non-metastatic disease treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2014
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 14 Oct 2014 New trial record